Emflaza

Deflazacort

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。
more
パッケージ あたり 錠剤 価格 節約 ご注文
180 tablet
¥ 107.07
¥ 19271.77¥ 107.07
¥ 34072.25
120 tablet
¥ 123.52
¥ 14822.72¥ 123.52
¥ 20739.95
90 tablet
¥ 148.22
¥ 13339.71¥ 148.22
¥ 13332.30
60 tablet
¥ 185.25
¥ 11115.19¥ 185.25
¥ 6666.15
30 tablet
¥ 296.36
¥ 8890.67¥ 296.36
パッケージ あたり 錠剤 価格 節約 ご注文
120 tablet
無料航空便配送 Hot
¥ 679.65
¥ 81558.35¥ 679.65
¥ 14800.48
90 tablet
無料航空便配送 Hot
¥ 716.71
¥ 64503.69¥ 716.71
¥ 7765.43
60 tablet
無料航空便配送 Hot
¥ 741.38
¥ 44483.00¥ 741.38
¥ 3696.41
36 tablet
無料航空便配送 Hot
¥ 782.50
¥ 28169.85¥ 782.50
¥ 737.80
24 tablet
¥ 802.99
¥ 19271.77¥ 802.99
パッケージ あたり 錠剤 価格 節約 ご注文
90 tablet
無料航空便配送 Hot
¥ 823.81
¥ 74143.28¥ 823.81
¥ 14809.75
60 tablet
無料航空便配送 Hot
¥ 889.68
¥ 53381.09¥ 889.68
¥ 5920.93
36 tablet
無料航空便配送 Hot
¥ 947.28
¥ 34101.91¥ 947.28
¥ 1479.31
24 tablet
無料航空便配送 Hot
¥ 988.37
¥ 23720.81¥ 988.37
Emflaza

ブランド

製造元

  • Lupin

病衣

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.